The effects of amiodarone on the thyroid

被引:356
作者
Martino, E
Bartalena, L
Bogazzi, F
Braverman, LE
机构
[1] Univ Insubria, Cattedra Endocrinol, Varese, Italy
[2] Boston Med Ctr, Sect Endocrinol Diabet & Nutr, Boston, MA 02118 USA
[3] Univ Pisa, Dipartimento Endocrinol & Metab, I-56124 Pisa, Italy
关键词
D O I
10.1210/er.22.2.240
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Amiodarone is a benzofuranic-derivative iodine-rich drug widely used for the treatment of tachyarrhythmias and, to a lesser extent, of ischemic heart disease. It often causes changes in thyroid function tests (typically an increase in serum T-4 and rT(3), and a decrease in serum T-3, concentrations), mainly related to the inhibition of 5'-deiodinase activity, resulting in a decrease in the generation of T-3 from T-4 and a decrease in the clearance of rT(3). in 14-18% of amiodarone-treated patients, there is overt thyroid dysfunction, either amiodarone-induced thyrotoxicosis (AIT) or amiodarone-induced hypothyroidism (AIH). Both AIT and AIH may develop either in apparently normal thyroid glands or in glands with preexisting, clinically silent abnormalities. Preexisting Hashimoto's thyroiditis is a definite risk factor for the occurrence of AIH. The pathogenesis of iodine-induced AW is related to a failure to escape from the acute Wolff-Chaikoff effect due to defects in thyroid hormonogenesis, and, in patients with positive thyroid autoantibody tests, to concomitant Hashimoto's thyroiditis. AIT is primarily related to excess iodine-induced thyroid hormone synthesis in an abnormal thyroid gland (type I AIT) or to amiodarone-related destructive thyroiditis (type II AIT), but mixed forms frequently exist. Treatment of AIH consists of L-T-4 replacement while continuing amiodarone therapy; alternatively, if feasible, amiodarone can be discontinued, especially in the absence of thyroid abnormalities, and the natural course toward euthyroidism can be accelerated by a short course of potassium perchlorate treatment. In type I AIT the main medical treatment consists of the simultaneous administration of thionamides and potassium perchlorate, while in type II AIT, glucocorticoids are the most useful therapeutic option. Mixed forms are best treated with a combination of thionamides, potassium perchlorate, and glucocorticoids. Radioiodine therapy is usually not feasible due to the low thyroidal radioiodine uptake, while thyroidectomy can be performed in cases resistant to medical therapy, with a slightly increased surgical risk.
引用
收藏
页码:240 / 254
页数:15
相关论文
共 152 条
[31]   EFFECT OF AMIODARONE ON SERUM TRIIODOTHYRONINE, REVERSE TRIIODOTHYRONINE, THYROXINE, AND THYROTROPIN - DRUG INFLUENCING PERIPHERAL METABOLISM OF THYROID-HORMONES [J].
BURGER, A ;
DINICHERT, D ;
NICOD, P ;
JENNY, M ;
LEMARCHANDBERAUD, T ;
VALLOTTON, MB .
JOURNAL OF CLINICAL INVESTIGATION, 1976, 58 (02) :255-259
[32]   EFFECT OF AMIODARONE ON MORTALITY AFTER MYOCARDIAL-INFARCTION - A DOUBLE-BLIND, PLACEBO-CONTROLLED, PILOT-STUDY [J].
CEREMUZYNSKI, L ;
KLECZAR, E ;
KRZEMINSKAPAKULA, M ;
KUCH, J ;
NARTOWICZ, E ;
SMIELAKKOROMBEL, J ;
DYDUSZYNSKI, A ;
MACIEJEWICZ, J ;
ZALESKA, T ;
LAZARCZYKKEDZIA, E ;
MOTYKA, J ;
PACZKOWSKA, B ;
SCZANIECKA, O ;
YUSUF, S .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 20 (05) :1056-1062
[33]  
CHEVIGNE-BRANCART M, 1983, Revue Medicale de Liege, V38, P269
[34]   STUDIES ON THE IN-VITRO CYTOTOXIC EFFECT OF AMIODARONE [J].
CHIOVATO, L ;
MARTINO, E ;
TONACCHERA, M ;
SANTINI, F ;
LAPI, P ;
MAMMOLI, C ;
BRAVERMAN, LE ;
PINCHERA, A .
ENDOCRINOLOGY, 1994, 134 (05) :2277-2282
[35]   Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery [J].
Daoud, EG ;
Strickberger, SA ;
Man, KC ;
Goyal, R ;
Deeb, GM ;
Bolling, SF ;
Pagani, FD ;
Bitar, D ;
Meissner, MD ;
Morady, F .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (25) :1785-1791
[36]   TREATMENT OF AMIODARONE INDUCED THYROTOXICOSIS WITH CARBIMAZOLE ALONE AND CONTINUATION OF AMIODARONE [J].
DAVIES, PH ;
FRANKLYN, JA ;
SHEPPARD, MC .
BRITISH MEDICAL JOURNAL, 1992, 305 (6847) :224-225
[37]   FETAL HYPOTHYROIDISM AS A COMPLICATION OF AMIODARONE TREATMENT FOR PERSISTENT FETAL SUPRAVENTRICULAR TACHYCARDIA [J].
DECATTE, L ;
DEWOLF, D ;
SMITZ, J ;
BOUGATEF, A ;
DESCHEPPER, J ;
FOULON, W .
PRENATAL DIAGNOSIS, 1994, 14 (08) :762-765
[38]  
DELANGE F, 2000, WERNER INGBARS THYRO, P295
[39]   FAILURE TO CONTROL HYPERTHYROIDISM WITH A THIONAMIDE AFTER KCIO4 WITHDRAWAL IN A PATIENT WITH AMIODARONE ASSOCIATED THYROTOXICOSIS [J].
DEWEWEIRE, A ;
UNGER, P ;
DELWICHE, F ;
UNGER, J .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1987, 10 (05) :529-529
[40]  
DEWOLF D, 1988, ACTA PAEDIATR SCAND, V77, P616